Answers are grounded in this paper and cite their sources.
In the United States, stimulants remain the approved pharmacotherapy of choice for adults with attention-deficit/hyperactivity disorder (ADHD). Many patients respond to these drugs, but stimulants also have a significant potential for misuse. This article suggests the "universal precautions" approach to reducing these risks while promoting appropriate medication use.
No takes yet. Share an insight, caveat, or question.
Modesto‐Lowe et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: